Variability of New Bone Mineral Metabolism Markers in Patients Treated with Maintenance Hemodialysis: Implications for Clinical Decision Making

被引：35

作者：

Cavalier, Etienne ^{[1
]}

Delanaye, Pierre ^{[1
]}

Moranne, Olivier ^{[2
]}

机构：

[1] Univ Liege, CHU Sart Tilman, Liege, Belgium

[2] CHU Nice, Nice, France

来源：

AMERICAN JOURNAL OF KIDNEY DISEASES | 2013年 / 61卷 / 05期

关键词：

FIBROBLAST GROWTH FACTOR-23; PARATHYROID-HORMONE; CALCIFICATION; MORTALITY;

D O I：

10.1053/j.ajkd.2012.12.013

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

100201 [内科学]; 100221 [泌尿外科学];

摘要：

引用

收藏

页码：847 / 848

页数：3

相关论文

共 10 条

[1]

FRASER CG, 1989, CRIT REV CL LAB SCI, V27, P409

[2]

Variability of Parathyroid Hormone and Other Markers of Bone Mineral Metabolism in Patients Receiving Hemodialysis [J].

Gardham, Clare ;

Stevens, Paul E. ;

Delaney, Michael P. ;

LeRoux, Marica ;

Coleman, Adrian ;

Lamb, Edmund J. .

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2010, 5 (07) :1261-1267

[3]

Garrett G, 2012, CLIN J AM SOC NEPHRO

[4]

Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis [J].

Gutierrez, Orlando M. ;

Mannstadt, Michael ;

Isakova, Tamara ;

Rauh-Hain, Jose Alejandro ;

Tamez, Hector ;

Shah, Anand ;

Smith, Kelsey ;

Lee, Hang ;

Thadhani, Ravi ;

Juppner, Harald ;

Wolf, Myles .

NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (06) :584-592

[5]

Role of fibroblast growth factor-23 in peripheral vascular calcification in non-diabetic and diabetic hemodialysis patients [J].

Inaba, M. ;

Okuno, S. ;

Imanishi, Y. ;

Yamada, S. ;

Shioi, A. ;

Yamakawa, T. ;

Ishimura, E. ;

Nishizawa, Y. .

OSTEOPOROSIS INTERNATIONAL, 2006, 17 (10) :1506-1513

[6]

High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients [J].

Jean, Guillaume ;

Terrat, Jean-Claude ;

Vanel, Thierry ;

Hurot, Jean-Marc ;

Lorriaux, Christie ;

Mayor, Brice ;

Chazot, Charles .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 2009, 24 (09) :2792-2796

[7]

Bone-specific alkaline phosphatase concentrations are less variable than those of parathyroid hormone in stable hemodialysis patients [J].

Sardiwal, Sunita ;

Gardham, Clare ;

Coleman, Adrian E. ;

Stevens, Paul E. ;

Delaney, Michael P. ;

Lamb, Edmund J. .

KIDNEY INTERNATIONAL, 2012, 82 (01) :100-105

[8]

Serum levels of TRAP5b, a new bone resorption marker unaffected by renal dysfunction, as a useful marker of cortical bone loss in hemodialysis patients [J].

Shidara, Kaori ;

Inaba, Masaaki ;

Okuno, Senji ;

Yamada, Shinsuke ;

Kumeda, Yasuro ;

Imanishi, Yasuo ;

Yamakawa, Tomoyuki ;

Ishimura, Eiji ;

Nishizawa, Yoshiki .

CALCIFIED TISSUE INTERNATIONAL, 2008, 82 (04) :278-287

[9]

Serum Fibroblast Growth Factor-23 Levels and Progression of Aortic Arch Calcification in Non-Diabetic Patients on Chronic Hemodialysis [J].

Tamei, Noriko ;

Ogawa, Tetsuya ;

Ishida, Hideki ;

Ando, Yoshitaka ;

Nitta, Kosaku .

JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2011, 18 (03) :217-223

[10]

Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards [J].

Vasikaran, S. ;

Eastell, R. ;

Bruyere, O. ;

Foldes, A. J. ;

Garnero, P. ;

Griesmacher, A. ;

McClung, M. ;

Morris, H. A. ;

Silverman, S. ;

Trenti, T. ;

Wahl, D. A. ;

Cooper, C. ;

Kanis, J. A. .

OSTEOPOROSIS INTERNATIONAL, 2011, 22 (02) :391-420